312 related articles for article (PubMed ID: 34780174)
21. Graph analysis of β2 adrenergic receptor structures: a "social network" of GPCR residues.
Sheftel S; Muratore KE; Black M; Costanzi S
In Silico Pharmacol; 2013; 1():16. PubMed ID: 25505660
[TBL] [Abstract][Full Text] [Related]
22. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.
Ring AM; Manglik A; Kruse AC; Enos MD; Weis WI; Garcia KC; Kobilka BK
Nature; 2013 Oct; 502(7472):575-579. PubMed ID: 24056936
[TBL] [Abstract][Full Text] [Related]
23. Mapping the allosteric sites of the A
Caliman AD; Miao Y; McCammon JA
Chem Biol Drug Des; 2018 Jan; 91(1):5-16. PubMed ID: 28639411
[TBL] [Abstract][Full Text] [Related]
24. Structural Basis for Activation of the Heterodimeric GABA
Kim Y; Jeong E; Jeong JH; Kim Y; Cho Y
J Mol Biol; 2020 Nov; 432(22):5966-5984. PubMed ID: 33058878
[TBL] [Abstract][Full Text] [Related]
25. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
[TBL] [Abstract][Full Text] [Related]
26. An investigation into the allosteric mechanism of GPCR A
Wang Q; Zhang S; Han Z; Fan H; Li C
J Biomol Struct Dyn; 2021 Oct; 39(17):6431-6439. PubMed ID: 32741308
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of allosteric regulation of β
Manna M; Niemelä M; Tynkkynen J; Javanainen M; Kulig W; Müller DJ; Rog T; Vattulainen I
Elife; 2016 Nov; 5():. PubMed ID: 27897972
[TBL] [Abstract][Full Text] [Related]
28. Elucidation of a dynamic interplay between a beta-2 adrenergic receptor, its agonist, and stimulatory G protein.
Han Y; Dawson JRD; DeMarco KR; Rouen KC; Bekker S; Yarov-Yarovoy V; Clancy CE; Xiang YK; Vorobyov I
Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2215916120. PubMed ID: 36853938
[TBL] [Abstract][Full Text] [Related]
29. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
30. Structural insights into binding specificity, efficacy and bias of a β
Masureel M; Zou Y; Picard LP; van der Westhuizen E; Mahoney JP; Rodrigues JPGLM; Mildorf TJ; Dror RO; Shaw DE; Bouvier M; Pardon E; Steyaert J; Sunahara RK; Weis WI; Zhang C; Kobilka BK
Nat Chem Biol; 2018 Nov; 14(11):1059-1066. PubMed ID: 30327561
[TBL] [Abstract][Full Text] [Related]
31. Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor.
Green SA; Spasoff AP; Coleman RA; Johnson M; Liggett SB
J Biol Chem; 1996 Sep; 271(39):24029-35. PubMed ID: 8798639
[TBL] [Abstract][Full Text] [Related]
32. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex.
Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z
ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197
[TBL] [Abstract][Full Text] [Related]
33. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
34. Activation/Deactivation Free-Energy Profiles for the β
Calderón JC; Ibrahim P; Gobbo D; Gervasio FL; Clark T
J Chem Inf Model; 2023 Oct; 63(20):6332-6343. PubMed ID: 37824365
[TBL] [Abstract][Full Text] [Related]
35. Allosteric communication regulates ligand-specific GPCR activity.
Ma N; Nivedha AK; Vaidehi N
FEBS J; 2021 Apr; 288(8):2502-2512. PubMed ID: 33738925
[TBL] [Abstract][Full Text] [Related]
36. Insight into partial agonism by observing multiple equilibria for ligand-bound and G
Solt AS; Bostock MJ; Shrestha B; Kumar P; Warne T; Tate CG; Nietlispach D
Nat Commun; 2017 Nov; 8(1):1795. PubMed ID: 29176642
[TBL] [Abstract][Full Text] [Related]
37. Biased Signaling in Mutated Variants of β
Madhu MK; Shewani K; Murarka RK
J Chem Inf Model; 2024 Jan; 64(2):449-469. PubMed ID: 38194225
[TBL] [Abstract][Full Text] [Related]
38. Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
Simpson LM; Wall ID; Blaney FE; Reynolds CA
Proteins; 2011 May; 79(5):1441-57. PubMed ID: 21337626
[TBL] [Abstract][Full Text] [Related]
39. State-dependent dynamics of extramembrane domains in the β
Nikte SV; Joshi M; Sengupta D
Proteins; 2024 Mar; 92(3):317-328. PubMed ID: 37864328
[TBL] [Abstract][Full Text] [Related]
40. Changes in conformation at the cytoplasmic ends of the fifth and sixth transmembrane helices of a yeast G protein-coupled receptor in response to ligand binding.
Umanah GK; Huang LY; Maccarone JM; Naider F; Becker JM
Biochemistry; 2011 Aug; 50(32):6841-54. PubMed ID: 21728340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
